BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37942579)

  • 21. The Côte d'Ivoire national HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data.
    Abouya L; Coulibaly IM; Wiktor SZ; Coulibaly D; N'kragbo M; N'gbo A; Zahui H; Touré K; Jacquemin K; San-Koffi M; Ackah A; Sassan-Morokro M; Maurice C; Whitaker JP; De Cock KM; Greenberg AE
    AIDS; 1998 Mar; 12(5):505-12. PubMed ID: 9543449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
    Taku O; Mbulawa ZZA; Phohlo K; Garcia-Jardon M; Businge CB; Williamson AL
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partners.
    Vernon SD; Unger ER; Piper MA; Severin ST; Wiktor SZ; Ghys PD; Miller DL; Horowitz IR; Greenberg AE; Reeves WC
    Sex Transm Infect; 1999 Aug; 75(4):258-60. PubMed ID: 10615313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
    Hall MT; Smith MA; Simms KT; Barnabas R; Murray JM; Canfell K
    Int J Cancer; 2021 Jul; 149(2):297-306. PubMed ID: 33634857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
    J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.
    Tawe L; MacDuffie E; Narasimhamurthy M; Wang Q; Gaseitsiwe S; Moyo S; Kasvosve I; Shin SS; Zetola NM; Paganotti GM; Grover S
    Int J Cancer; 2020 Mar; 146(6):1667-1673. PubMed ID: 31325316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV status.
    Boni S; Tchounga B; Comoe K; Guie P; Adié M; Horo A; Messou E; Ekouévi DK; Dabis F; Adoubi I; Jaquet A
    Int J Gynaecol Obstet; 2019 Nov; 147(2):246-251. PubMed ID: 31482577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs and Scale-Up Costs of Integrating HIV Self-Testing Into Civil Society Organisation-Led Programmes for Key Populations in Côte d'Ivoire, Senegal, and Mali.
    d'Elbée M; Traore MM; Badiane K; Vautier A; Simo Fotso A; Kabemba OK; Rouveau N; Godfrey-Faussett P; Maheu-Giroux M; Boily MC; Medley GF; Larmarange J; Terris-Prestholt F
    Front Public Health; 2021; 9():653612. PubMed ID: 34109146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
    De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
    Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
    Metz CK; Skof AS; Sehouli J; Siedentopf JP; Gebert P; Weiss F; Alba Alejandre I; Heinrich-Rohr M; Weizsaecker K; Henrich W; Kaufmann AM; Rohr I
    Arch Gynecol Obstet; 2023 Jul; 308(1):207-218. PubMed ID: 36576558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Côte d'Ivoire.
    Switzer WM; Tang S; Zheng H; Shankar A; Sprinkle PS; Sullivan V; Granade TC; Heneine W
    PLoS One; 2016; 11(6):e0157709. PubMed ID: 27310836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
    Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Sparén P; Dillner J
    AIDS; 2021 Nov; 35(14):2367-2374. PubMed ID: 34723851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Prevalence of Cervical High-Risk Human Papillomavirus Harboring Atypical Genotypes in Human Immunodeficiency Virus -Infected and -Uninfected First-Generation Adult Immigrant Women Originating from Sub-Saharan Africa and Living in France.
    Mboumba Bouassa RS; Gubavu C; Veyer D; Robin L; Gravier A; Hocqueloux L; Prazuck T; Péré H; Bélec L;
    J Immigr Minor Health; 2021 Apr; 23(2):308-319. PubMed ID: 32816173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anal Intercourse Among Female Sex Workers in Côte d'Ivoire: Prevalence, Determinants, and Model-Based Estimates of the Population-Level Impact on HIV Transmission.
    Maheu-Giroux M; Baral S; Vesga JF; Diouf D; Diabaté S; Alary M; Abo K; Boily MC
    Am J Epidemiol; 2018 Feb; 187(2):287-297. PubMed ID: 28633387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peer Recruitment Strategies for Female Sex Workers Not Engaged in HIV Prevention and Treatment Services in Côte d'Ivoire: Program Data Analysis.
    Olawore O; Astatke H; Lillie T; Persaud N; Lyons C; Kamali D; Wilcher R; Baral S
    JMIR Public Health Surveill; 2020 Oct; 6(4):e18000. PubMed ID: 33001039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance Among Women in Senegal, West Africa.
    Li Z; Winer RL; Ba S; Sy MP; Lin J; Feng Q; Gottlieb GS; Salif Sow P; Kiviat NB; Hawes SE
    J Infect Dis; 2023 Apr; 227(9):1088-1096. PubMed ID: 36314598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV.
    Kahesa C; Thomsen LT; Linde DS; Mchome B; Katanga J; Swai P; Manongi R; Kjaerem M; Iftner T; Waldstrøm M; Mwaiselage J; Rasch V; Kjaer SK
    Int J Cancer; 2023 Feb; 152(4):686-696. PubMed ID: 36093587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus prevalence and genotype distribution among HIV-infected women in Korea.
    Park EK; Cho H; Lee SH; Lee SG; Lee SY; Kim KH; Lee CH; Chung JS; Kwak IS
    J Korean Med Sci; 2014 Jan; 29(1):32-7. PubMed ID: 24431902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity in the Prevalence of High-Risk Human Papillomavirus Infection in Human Immunodeficiency Virus-Negative and Human Immunodeficiency Virus-Positive Men Who Have Sex With Men in West Africa.
    Yaya I; Boyer V; Ehlan PA; Coulibaly A; Agboyibor MK; Traoré I; Kouamé MJ; Maiga AK; Kotchi OR; Nyasenu YT; Maradan G; Rojas-Castro D; Diallo F; Anoma C; Dah TTE; Mensah E; Dembélé Keita B; Spire B; Dagnra CA; Laurent C;
    Clin Infect Dis; 2021 Dec; 73(12):2184-2192. PubMed ID: 33606001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.